Brian Doyle, MD
Ophthalmology · Montpelier, VTNPI 1083905590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Bausch & Lomb Americas Inc.. That places this record below the midpoint for ophthalmology clinicians in VT, where the typical reported total is $21.
Across 1 payment — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$21
What the payments were for
- Food & beverage$21100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 1 | $21 |
How this compares
$21 in reported general payments places this provider in the 50th percentile of 35 ophthalmology providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 53 | $76,539 |
| LumiganBimatoprost | 66 | $35,389 |
| RhopressaNetarsudil Mesylate | 63 | $32,652 |
| Cyclosporine | 31 | $24,960 |
| CombiganBrimonidine Tartrate/Timolol | 24 | $12,448 |
| Latanoprost | 590 | $9,453 |
| Brinzolamide | 39 | $7,334 |
| Prednisolone Acetate | 227 | $6,495 |
| Brimonidine Tartrate | 128 | $6,443 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 22 | $6,420 |
| Timolol Maleate | 139 | $3,697 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 103 | $3,512 |
| Travoprost | 14 | $2,751 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 15 | $2,426 |
| MoxifloxacinMoxifloxacin Hcl | 51 | $1,633 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Montpelier
- Christopher ConnorWindsor$187K
- Shaunak BakshiSouth Burlington$4K
- John HinkleSouth Burlington$4K
- Jonathan ManhardSouth Burlington$2K
- Stephen PhippsSt Johnsbury$1K
- Jillian KaplitaMiddlebury$1K
- Praveen KeshavaRutland$360
- Chantal BoisvertBurlington$324
- Miranda RenfrowSaint Johnsbury$313
- David TerrellBrattleboro$259
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.